Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research “CTCs are rare — as low as only 1–10 can [...] By digitalstudios|2024-06-27T20:27:49+00:00June 27, 2024|3rd Party Medical Device Industry News|Comments Off on Bio-Rad Launches Celselect Slides 2.0 to Advance Rare Cell and Circulating Tumor Cell Enrichment for Cancer Research Read More
